Sorrento Therapeutics (SRNE) Short Interest Ratio & Short Volume $0.0024 +0.00 (+84.62%) As of 07/11/2025 03:46 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFDA EventsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sorrento Therapeutics Short Interest DataSorrento Therapeutics (SRNE) has a short interest of 3.61 million shares, representing 0.67% of the float (the number of shares available for trading by the public). This marks a 2.62% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.2, indicating that it would take 10.2 days of the average trading volume of 92,222 shares to cover all short positions.Current Short Interest3,609,300 sharesPrevious Short Interest3,517,100 sharesChange Vs. Previous Month+2.62%Dollar Volume Sold Short$5.05 thousandShort Interest Ratio10.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares551,280,000 sharesShort Percent of Float0.67%Today's Trading Volume78,192 sharesAverage Trading Volume92,222 sharesToday's Volume Vs. Average85% Short Selling Sorrento Therapeutics? Sign up to receive the latest short interest report for Sorrento Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSRNE Short Interest Over TimeSRNE Days to Cover Over TimeSRNE Percentage of Float Shorted Over Time Sorrento Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20253,609,300 shares $5.05 thousand +2.6%0.7%10.2 $0.00 6/15/20253,517,100 shares $7.39 thousand 0.0%0.7%27 $0.00 5/31/20253,517,500 shares $4.57 thousand No Change0.7%18.9 $0.00 5/15/20253,517,500 shares $4.22 thousand -0.7%N/A13.2 $0.00 4/30/20253,543,600 shares $3.19 thousand -0.1%N/A18.6 $0.00 4/15/20253,546,100 shares $3.55 thousand 0.0%N/A35.4 $0.00 3/14/20253,548,200 shares $2.48 thousand No ChangeN/A18.7 $0.00 2/14/20253,536,100 shares $2.12 thousand -3.1%N/A31 $0.00 1/31/20253,650,700 shares $1.46 thousand +0.0%N/A22.1 $0.00 1/15/20253,649,800 shares $1.82 thousand No ChangeN/A31.6 $0.00 Get the Latest News and Ratings for SRNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202364,560,000 shares $61.88 million +3.3%N/A5.8 $0.96 1/15/202362,480,000 shares $70.60 million +1.7%N/A6.1 $1.13 12/30/202261,440,000 shares $54.44 million +3.6%N/A6.3 $0.89 12/15/202259,330,000 shares $62.89 million -4.3%N/A7 $1.06 11/30/202261,990,000 shares $80.59 million +7.1%N/A8.5 $1.30 11/15/202257,910,000 shares $95.55 million -3.7%N/A8 $1.65 10/31/202260,120,000 shares $94.39 million -0.9%N/A7.9 $1.57 10/15/202260,670,000 shares $81.30 million +3.4%N/A7.7 $1.34 9/30/202258,680,000 shares $92.13 million +3.9%N/A6.9 $1.57 9/15/202256,500,000 shares $118.09 million +4.4%N/A6 $2.09 8/31/202254,110,000 shares $110.93 million -1.9%N/A5.1 $2.05 8/15/202255,130,000 shares $151.61 million -8.4%N/A5.3 $2.75 7/31/202260,200,000 shares $156.52 million +5.7%N/A5.8 $2.60 7/15/202256,970,000 shares $148.12 million -5.2%N/A5.3 $2.60 6/30/202260,070,000 shares $120.74 million +15.6%N/A5.7 $2.01 6/15/202251,960,000 shares $84.69 million -3.9%N/A5.2 $1.63 5/31/202254,080,000 shares $88.69 million +2.1%N/A5.7 $1.64 5/15/202252,970,000 shares $75.75 million -3.1%N/A5.6 $1.43 4/30/202254,660,000 shares $82.54 million +2.0%N/A6.1 $1.51 4/15/202253,580,000 shares $101.27 million +2.3%N/A5.9 $1.89 3/31/202252,390,000 shares $122.07 million +16.5%N/A6.2 $2.33 3/15/202244,990,000 shares $97.18 million -2.6%N/A5.5 $2.16 2/28/202246,210,000 shares $116.91 million +1.5%N/A6.5 $2.53 2/15/202245,520,000 shares $142.02 million -1.5%16.1%6.7 $3.12 1/31/202246,190,000 shares $159.36 million +10.7%16.3%7 $3.45 1/15/202241,720,000 shares $190.24 million -2.7%14.7%7.2 $4.56 12/31/202142,890,000 shares $199.44 million -2.9%15.2%8.1 $4.65 12/15/202144,150,000 shares $272.85 million -2.7%15.6%8.4 $6.18 11/30/202145,360,000 shares $270.35 million +0.1%16.0%9.2 $5.96 11/15/202145,320,000 shares $276.91 million -0.6%16.0%9.5 $6.11The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $7 10/29/202145,600,000 shares $312.82 million -0.9%16.3%9.7 $6.86 10/15/202146,030,000 shares $314.85 million +0.8%16.5%9.9 $6.84 9/30/202145,660,000 shares $348.39 million +6.0%16.4%9.4 $7.63 9/15/202143,070,000 shares $341.98 million -0.5%15.5%7.5 $7.94 8/31/202143,290,000 shares $389.61 million -7.2%15.7%6.9 $9.00 8/13/202146,640,000 shares $421.63 million -3.7%17.0%7.1 $9.04 7/30/202148,420,000 shares $397.53 million +0.2%17.6%7.2 $8.21 7/15/202148,330,000 shares $382.77 million -4.0%17.6%6.7 $7.92 6/30/202150,360,000 shares $487.99 million -0.9%18.4%6.6 $9.69 6/15/202150,830,000 shares $455.44 million +0.3%18.9%7 $8.96 5/28/202150,660,000 shares $380.96 million -5.2%18.8%7.1 $7.52 5/14/202153,420,000 shares $339.22 million -5.6%N/A6.4 $6.35 4/30/202156,610,000 shares $480.05 million -4.9%N/A5.4 $8.48 4/15/202159,550,000 shares $439.78 million +6.4%N/A4.1 $7.39 3/31/202155,980,000 shares $447.84 million -0.2%N/A3.4 $8.00 3/15/202156,070,000 shares $574.72 million -1.5%N/A3.2 $10.25 2/26/202156,940,000 shares $576.23 million -11.2%N/A3.1 $10.12 2/12/202164,150,000 shares $957.76 million +6.9%N/A3.4 $14.93 1/29/202160,020,000 shares $734.04 million -14.8%N/A3.1 $12.23 1/15/202170,470,000 shares $563.06 million -4.2%N/A4.2 $7.99 12/31/202073,590,000 shares $532.42 million +6.7%N/A5.1 $7.24 12/15/202068,980,000 shares $516.66 million +0.1%N/A4.1 $7.49 11/30/202068,910,000 shares $561.62 million -8.6%N/A3.3 $8.15 11/15/202075,390,000 shares $486.27 million +3.6%N/A3.4 $6.45 10/30/202072,750,000 shares $529.62 million +1.2%N/A2.6 $7.28 10/15/202071,880,000 shares $725.99 million -5.1%N/A1.8 $10.10 9/30/202075,730,000 shares $844.39 million +0.8%N/A1.8 $11.15 9/15/202075,110,000 shares $521.26 million +2.4%N/A1.7 $6.94 8/31/202073,350,000 shares $587.53 million +35.7%N/A1.8 $8.01 8/14/202054,060,000 shares $672.51 million +3.4%N/A1.3 $12.44 7/31/202052,300,000 shares $466.52 million +8.0%N/A1.1 $8.92 7/15/202048,410,000 shares $318.54 million -3.3%N/A1.3 $6.58 SRNE Short Interest - Frequently Asked Questions What is Sorrento Therapeutics' current short interest? Short interest is the volume of Sorrento Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 3,609,300 shares of SRNE short. 0.67% of Sorrento Therapeutics' shares are currently sold short. Learn More on Sorrento Therapeutics' current short interest. What is a good short interest ratio for Sorrento Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SRNE shares currently have a short interest ratio of 10.0. Learn More on Sorrento Therapeutics's short interest ratio. What is a good short interest percentage for Sorrento Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.67% of Sorrento Therapeutics' floating shares are currently sold short. Is Sorrento Therapeutics' short interest increasing or decreasing? Sorrento Therapeutics saw a increase in short interest in June. As of June 30th, there was short interest totaling 3,609,300 shares, an increase of 2.6% from the previous total of 3,517,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sorrento Therapeutics' short interest compare to its competitors? 0.67% of Sorrento Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sorrento Therapeutics: Spruce Biosciences, Inc. (0.12%), Enveric Biosciences, Inc. (12.57%), Galmed Pharmaceuticals Ltd. (4.17%), PMGC Holdings Inc. (10.58%), Affimed (4.46%), PainReform Ltd. (7.44%), Aditxt, Inc. (9.34%), Psyence Biomedical Ltd. (2.92%), Oragenics, Inc. (45.59%), GRI Bio, Inc. (2.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Sorrento Therapeutics stock? Short selling SRNE is an investing strategy that aims to generate trading profit from Sorrento Therapeutics as its price is falling. SRNE shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sorrento Therapeutics? A short squeeze for Sorrento Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SRNE, which in turn drives the price of the stock up even further. How often is Sorrento Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRNE, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Spruce Biosciences Short Interest Data Enveric Biosciences Short Interest Data Galmed Pharmaceuticals Short Interest Data PMGC Short Interest Data Affimed Short Interest Data PainReform Short Interest Data Aditxt Short Interest Data Psyence Biomedical Short Interest Data Oragenics Short Interest Data GRI Bio Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SRNE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.